Increase in N-terminal fragment of the prohormone brain-type natriuretic peptide as a measure for predicting outcome after urgent heart transplantation

被引:5
作者
Komoda, Takeshi [1 ]
Hetzer, Roland [1 ]
Knosalla, Christoph [1 ]
Dandel, Michael [1 ]
Lehmkuhl, Hans B. [1 ]
机构
[1] Deutsch Herzzentrum Berlin, Dept Cardiothorac & Vasc Surg, D-13353 Berlin, Germany
关键词
Heart failure; Heart transplantation; Prognosis; Natriuretic peptide; Brain; Biological markers; ALLOGRAFT VASCULOPATHY; EMERGENCY DIAGNOSIS; RISK STRATIFICATION; FAILURE PATIENTS; PROBNP; MORTALITY; DYSPNEA; EVENTS; ATRIAL; MARKER;
D O I
10.1016/j.ejcts.2009.09.029
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: When candidates in urgent status for heart transplantation (HTx) show high levels of N-terminal brain-type natriuretic peptide (NT-proBNP), the prognosis of the patients is poor. However, identification of these high-risk patients is a matter for discussion. We investigated increase of NT-proBNP after listing with Eurotransplant for urgent HTx as a measure to predict outcome after HTx. Methods: Plasma NT-proBNP was measured before and after urgency listing in 72 HTx candidates who did not receive mechanical circulatory support. The ratio of the increase in maximal value of NT-proBNP after the urgency listing compared with that before the urgency listing was defined as delta max NT-proBNP. When the cut-off value for this parameter was determined as 20%, 23 patients were assigned to the group with an increase in maximal NT-proBNP value after urgency listing (group INC) and the rest to group NON (n = 49). We evaluated the over 20% increase in maximal NT-proBNP value after urgency listing as a prognostic factor after urgent HTx. Results: Actuarial survival in group INC was significantly worse than in group NON (p = 0.040). The 30-day mortality rate after HTx in group INC was significantly higher than in group NON (39.1% vs 12.2%, p = 0.013). Incidence of infection and frequency of prolonged mechanical respiratory support (longer than 4 days) were significantly higher in group INC than in group NON (60.9% vs 18.4%, p = 0.0008, 91.3% vs 55.1%, p = 0.0027, respectively). Univariate Cox regression analysis demonstrated that the over 20% increase in maximal NT-proBNP value after urgency listing, age at HTx and donor age were significant risk factors for mortality. Multivariate Cox regression analysis revealed that the over 20% increase in maximal NT-proBNP value was the sole significant risk factor for mortality (hazard ratio 2.441, 95% confidence interval 1.061-5.618, p = 0.036). Conclusions: Patients with over 20% increase in the maximal NT-proBNP value after urgency listing are at higher risk for post-HTx mortality and complications. Ventricular assist device (VAD) implantation may be a socially valid approach in these patients. (C) 2009 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:864 / 869
页数:6
相关论文
共 26 条
[1]   DANGERS OF USING OPTIMAL CUTPOINTS IN THE EVALUATION OF PROGNOSTIC FACTORS [J].
ALTMAN, DG ;
LAUSEN, B ;
SAUERBREI, W ;
SCHUMACHER, M .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1994, 86 (11) :829-835
[2]   Probrain natriuretic peptide and C-reactive protein as markers of acute rejection, allograft vasculopathy, and mortality in heart transplantation [J].
Arora, Satish ;
Gullestad, Lars ;
Wergeland, Ragnhild ;
Simonsen, Svein ;
Holm, Torbjorn ;
Hognestad, Aina ;
Ueland, Thor ;
Geiran, Odd ;
Andreassen, Arne .
TRANSPLANTATION, 2007, 83 (10) :1308-1315
[3]   N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients [J].
Bettencourt, P ;
Azevedo, A ;
Pimenta, J ;
Frioes, F ;
Ferreira, S ;
Ferreira, A .
CIRCULATION, 2004, 110 (15) :2168-2174
[4]   Risk stratification in chronic heart failure: Independent and incremental prognostic value of echocardiography and brain natriuretic peptide and its N-terminal fragment [J].
Bruch, C ;
Rothenburger, M ;
Gotzmann, M ;
Sindermann, J ;
Scheld, HH ;
Breithardt, G ;
Wichter, T .
JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY, 2006, 19 (05) :522-528
[5]   Analytical performance of the N terminal pro B type natriuretic peptide (NT-proBNP) assay on the Elecsys™ 1010 and 2010 analysers [J].
Collinson, PO ;
Barnes, SC ;
Gaze, DC ;
Galasko, G ;
Lahiri, A ;
Senior, R .
EUROPEAN JOURNAL OF HEART FAILURE, 2004, 6 (03) :365-368
[6]   A change in N-terminal pro-brain natriuretic peptide is predictive of outcome in patients with advanced heart failure [J].
Gardner, Roy S. ;
Chong, Kwok S. ;
Morton, James J. ;
McDonagh, Theresa A. .
EUROPEAN JOURNAL OF HEART FAILURE, 2007, 9 (03) :266-271
[7]   N-terminal brain natriuretic peptide is predictive of death after cardiac transplantation [J].
Gardner, RS ;
Chong, KS ;
Murday, AJ ;
Morton, JJ ;
McDonagh, TA .
HEART, 2006, 92 (01) :121-123
[8]   N-terminal pro-brain natriuretic peptide -: A new gold standard in predicting mortality in patients with advanced heart failure [J].
Gardner, RS ;
Özalp, F ;
Murday, AJ ;
Robb, SD ;
McDonagh, TA .
EUROPEAN HEART JOURNAL, 2003, 24 (19) :1735-1743
[9]   B-type natriuretic peptide predicts future cardiac events in patients presenting to the emergency department with dyspnea [J].
Harrison, A ;
Morrison, LK ;
Krishnaswamy, P ;
Kazanegra, R ;
Clopton, P ;
Dan, Q ;
Hlavin, P ;
Maisel, AS .
ANNALS OF EMERGENCY MEDICINE, 2002, 39 (02) :131-138
[10]   The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study [J].
Januzzi, JL ;
Camargo, CA ;
Anwaruddin, S ;
Baggish, AL ;
Chen, AA ;
Krauser, DG ;
Tung, R ;
Cameron, R ;
Nagurney, JT ;
Chae, CU ;
Lloyd-Jones, DM ;
Brown, DF ;
Foran-Melanson, S ;
Sluss, PM ;
Lee-Lewandrowski, EL ;
Lewandrowski, KB .
AMERICAN JOURNAL OF CARDIOLOGY, 2005, 95 (08) :948-954